GLP-1 inhibitors are enacting great changes throughout health care.
The drugs reduce the amount a patient eats, leading them to lose weight or maintain healthier blood glucose levels. Their...
The Book Of GLP-1s: For Medtech They Giveth, As Well As Taketh Away
GLP-1 inhibitors for weight loss are rapidly threatening several medtech segments; however, in ensuring their long-term efficacy, digital health companies could benefit.
More from Digital Technologies
More from Medtech Insight
• By
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
• By
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
• By
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.